News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,223 Results
Type
Article (43510)
Company Profile (360)
Press Release (656353)
Section
Business (207511)
Career Advice (2001)
Deals (35883)
Drug Delivery (96)
Drug Development (83662)
Employer Resources (170)
FDA (16565)
Job Trends (15052)
News (351838)
Policy (33168)
Tag
Academia (2662)
Alliances (50376)
Alzheimer's disease (1258)
Approvals (16468)
Artificial intelligence (119)
Bankruptcy (356)
Best Places to Work (11661)
Biotechnology (259)
Breast cancer (106)
Cancer (924)
Cardiovascular disease (79)
Career advice (1671)
Cell therapy (219)
Clinical research (65976)
Collaboration (333)
Compensation (159)
COVID-19 (2600)
Cystic fibrosis (82)
Data (820)
Diabetes (135)
Diagnostics (6210)
Drug pricing (84)
Earnings (84878)
Employer resources (147)
Events (111562)
Executive appointments (241)
FDA (16990)
Funding (288)
Gene therapy (167)
GLP-1 (606)
Government (4430)
Healthcare (19151)
Infectious disease (2670)
Inflammatory bowel disease (108)
Interviews (309)
IPO (16492)
Job creations (3687)
Job search strategy (1427)
Layoffs (434)
Legal (7947)
Lung cancer (162)
Manufacturing (154)
Medical device (13373)
Medtech (13378)
Mergers & acquisitions (19386)
Metabolic disorders (376)
Neuroscience (1504)
NextGen Class of 2024 (6697)
Non-profit (4561)
Northern California (1154)
Obesity (224)
Opinion (192)
Patents (96)
People (57147)
Phase I (20508)
Phase II (29005)
Phase III (21702)
Pipeline (198)
Postmarket research (2710)
Preclinical (8744)
Radiopharmaceuticals (250)
Rare diseases (195)
Real estate (5993)
Regulatory (22011)
Research institute (2412)
Resumes & cover letters (351)
Southern California (1052)
Startups (3693)
United States (11513)
Vaccines (557)
Weight loss (177)
Date
Today (223)
Last 7 days (802)
Last 30 days (2926)
Last 365 days (37135)
2024 (30726)
2023 (41051)
2022 (52296)
2021 (56829)
2020 (55103)
2019 (47639)
2018 (35958)
2017 (33036)
2016 (32438)
2015 (38445)
2014 (32164)
2013 (27177)
2012 (29331)
2011 (30045)
2010 (28196)
Location
Africa (741)
Arizona (190)
Asia (38323)
Australia (6335)
California (2660)
Canada (1150)
China (210)
Colorado (116)
Connecticut (117)
Europe (84128)
Florida (381)
Georgia (101)
Illinois (315)
Indiana (179)
Kansas (98)
Maryland (509)
Massachusetts (2199)
Michigan (142)
Minnesota (246)
New Jersey (804)
New York (810)
North Carolina (705)
Northern California (1154)
Ohio (125)
Pennsylvania (740)
South America (1116)
Southern California (1052)
Texas (370)
Washington State (316)
700,223 Results for "xcyte therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced that CEO Lance Alstodt will participate at the Jefferies Global Healthcare Conference being held June 5-6, 2024 at the Marriot Marquis in New York.
June 4, 2024
·
3 min read
Biotech Beach
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.
Oncotelic Therapeutics, Inc., announced that it has entered into a binding term-sheet with Mosaic ImmunoEngineering, Inc. under which Mosaic will acquire rights to Oncotelic’s clinical-stage necroptosis cancer therapies.
April 29, 2024
·
7 min read
Biotech Beach
Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy Response in Tumors
Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, launch a new assay for quantifying pharmacodynamic markers of radioligand therapies in tumors.
May 31, 2024
·
3 min read
Press Releases
RxCell Inc. Granted U.S. Patent for iPSC-based Cell Therapy
September 19, 2024
·
2 min read
Policy
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.
June 20, 2024
·
2 min read
Press Releases
Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago
October 15, 2024
·
2 min read
Press Releases
Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases
October 16, 2024
·
6 min read
Press Releases
EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations
September 4, 2024
·
2 min read
Drug Development
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication
Ocugen, Inc. announced that the first patient has been dosed in its Phase 3 liMeliGhT clinical trial for OCU400—a modifier gene therapy product candidate being developed for retinitis pigmentosa.
June 20, 2024
·
7 min read
Drug Development
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced preclinical data from the Company’s platform and pipeline.
April 22, 2024
·
4 min read
1 of 70,023
Next
